NCAM1 and Sjogren syndrome: Our study found that the absolute count of CD16+CD56+ NK cells was significantly lower in both pSS groups compared to healthy controls, which may disrupt immune surveillance and contribute to the higher incidence of tumors in patients with Sjögren’s syndrome [38].